
OSTEOARTHRITIS
Platelet-rich plasma more effective than placebo for knee OA at 6 months
This report has been verified
by one or more authors of the
original publication.
Br J Sports Med. 2015 May;49(10):657-672
6 randomized controlled trials (RCTs) and 4 non-randomized clinical trials with a total of 1110 patients were included in this systematic review and meta-analysis to determine the effectiveness of platelet-rich plasma (PRP) injections in patients with osteoarthritis (OA) of the knee. Results demonstrated a significant reduction in pain in patients treated with PRP compared to patients treated with placebo or hyaluronic acid injections. Additionally, WOMAC physical function was also seen to significantly favor PRP treatment in comparison to the placebo and hyaluronic acid injection groups. Results from the systematic review and meta-analysis should be interpreted with caution as the majority of the trials included were associated with a high risk of bias and there was significant heterogeneity in the outcomes assessed.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in


Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now